Olanzapine ODT 20mg Tablets

Manufacturer DR. REDDY'S Active Ingredient Olanzapine Orally Disintegrating Tablets(oh LAN za peen) Pronunciation oh LAN za peen
WARNING: There is a higher chance of death in older adults who take this drug for mental problems caused by dementia. Most of the deaths were linked to heart disease or infection. This drug is not approved to treat mental problems caused by dementia. @ COMMON USES: It is used to treat bipolar disorder. It is used to treat schizophrenia.It is used to treat depression.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antipsychotic
đŸ§Ŧ
Pharmacologic Class
Atypical antipsychotic; Dopamine and serotonin receptor antagonist
🤰
Pregnancy Category
Category C
✅
FDA Approved
Sep 2000
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Olanzapine ODT is a medication used to treat mental health conditions like schizophrenia and bipolar disorder. It helps balance certain chemicals in the brain to improve mood, thinking, and behavior. The ODT (Orally Disintegrating Tablet) form dissolves quickly in your mouth without water.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely.

Stay hydrated by drinking plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.
Be mindful of your fluid intake in hot weather or when engaging in physical activity to avoid dehydration.
You can take this medication with or without food. If it causes stomach upset, take it with food to help alleviate this issue.

Important Administration Instructions

Continue taking your medication as directed by your doctor or healthcare provider, even if you start feeling better.
When opening the foil packaging, do not push the tablet out. Instead, use dry hands to remove it and place it on your tongue, allowing it to dissolve. You do not need water to take this medication. Do not swallow the tablet whole, and avoid chewing, breaking, or crushing it.

Special Considerations

If you have phenylketonuria (PKU), consult with your doctor before taking this medication, as some products may contain phenylalanine.

Storing and Disposing of Your Medication

Store your medication at room temperature, protected from light and moisture. Avoid storing it in a bathroom.
Use the oral-disintegrating tablet immediately after opening the pouch. Discard any unused portion of the pouch.
Keep all medications in a safe place, out of the reach of children and pets.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember.
If it is close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule.
Do not take two doses at the same time or take extra doses to make up for a missed dose.
💡

Lifestyle & Tips

  • Take exactly as prescribed, usually once a day.
  • Do not chew or crush the ODT tablet; allow it to dissolve on your tongue.
  • Avoid alcohol and other CNS depressants, as they can increase sedation.
  • Be aware of potential weight gain and metabolic changes; maintain a healthy diet and exercise routine.
  • Monitor for dizziness when standing up (orthostatic hypotension); rise slowly.
  • Report any new or worsening side effects to your doctor.
  • Do not stop taking this medication suddenly without consulting your doctor, as it can lead to withdrawal symptoms or worsening of your condition.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 10-15 mg once daily (Schizophrenia); 10-15 mg once daily (Bipolar I Mania); 5-20 mg once daily (Bipolar I Maintenance)
Dose Range: 5 - 20 mg

Condition-Specific Dosing:

schizophrenia: Initial 5-10 mg once daily, target 10-15 mg/day. Max 20 mg/day.
bipolar_mania: Initial 10-15 mg once daily (monotherapy) or 10 mg once daily (combination). Max 20 mg/day.
bipolar_maintenance: Initial 5-20 mg once daily, based on prior response.
agitation_schizophrenia_bipolar_mania: 10 mg ODT once, may repeat after 2 hours, max 30 mg/day (for acute agitation, often IM is preferred for rapid effect).
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established (Safety and efficacy not established for children <13 years for schizophrenia/bipolar mania).
Adolescent: Schizophrenia (13-17 years): Initial 2.5-5 mg once daily, target 10 mg/day. Max 20 mg/day. Bipolar I Mania (13-17 years): Initial 2.5-5 mg once daily, target 10 mg/day. Max 20 mg/day.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment necessary.
Moderate: No dosage adjustment necessary.
Severe: No dosage adjustment necessary, but caution advised due to limited experience.
Dialysis: No dosage adjustment necessary, but caution advised due to limited experience.

Hepatic Impairment:

Mild: No dosage adjustment necessary.
Moderate: Consider lower starting dose (e.g., 5 mg/day) and titrate cautiously.
Severe: Not available (Use with caution, consider lower starting dose).

Pharmacology

đŸ”Ŧ

Mechanism of Action

Olanzapine is an atypical antipsychotic that exhibits antagonism at multiple receptors, including dopamine D1, D2, D3, D4, and D5 receptors, serotonin 5-HT2A, 5-HT2C, 5-HT3, and 5-HT6 receptors, muscarinic M1-M5 receptors, alpha-1 adrenergic receptors, and histamine H1 receptors. Its antipsychotic activity is thought to be mediated through a combination of dopamine D2 and serotonin 5-HT2A antagonism.
📊

Pharmacokinetics

Absorption:

Bioavailability: Not available (well absorbed, but subject to first-pass metabolism)
Tmax: 5-8 hours
FoodEffect: Food does not affect the rate or extent of absorption.

Distribution:

Vd: 1000 L (approximately)
ProteinBinding: 93% (primarily to albumin and alpha1-acid glycoprotein)
CnssPenetration: Yes

Elimination:

HalfLife: 21-54 hours (mean 33 hours)
Clearance: Not available (mean 27 L/hr)
ExcretionRoute: Renal (57%), Fecal (30%)
Unchanged: 7% (renal)
âąī¸

Pharmacodynamics

OnsetOfAction: Days to weeks for full antipsychotic effect; hours for sedation/agitation control.
PeakEffect: Not available (variable based on indication)
DurationOfAction: 24 hours (allows once-daily dosing)

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Olanzapine is not approved for the treatment of patients with dementia-related psychosis. Antidepressants increased the risk compared to placebo of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Olanzapine is not approved for use in pediatric patients with depression.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Drowsiness
+ Unusual thirst or hunger
+ Frequent urination
+ Flushing
+ Rapid breathing
+ Fruity-smelling breath
Movement problems, such as:
+ Trouble controlling body movements
+ Twitching
+ Changes in balance
+ Difficulty swallowing or speaking
New or worsening mental, mood, or behavioral changes, including:
+ Thoughts of self-harm or suicide
Severe dizziness or fainting
Abnormal heart rhythms (fast or slow heartbeat)
Inability to sweat during physical activity or in warm temperatures
Seizures
Drooling
Changes in vision
Memory problems or loss
Chest pain
Swelling
Abnormal sensations, such as burning, numbness, or tingling
Difficulty urinating
Hormonal changes, including:
+ Enlarged breasts
+ Nipple discharge
+ Erectile dysfunction
+ Menstrual changes
Swollen glands
Neuroleptic malignant syndrome (NMS), a potentially life-threatening condition, characterized by:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion
+ Changes in thinking
+ Rapid heartbeat
+ Abnormal heartbeat
+ Excessive sweating
Low white blood cell counts, which can increase the risk of infection; if you have a history of low white blood cell counts, inform your doctor and seek medical attention if you experience:
+ Fever
+ Chills
+ Sore throat
Tardive dyskinesia, a severe muscle problem, which may cause:
+ Involuntary movements
+ Tongue sticking out
+ Puffing cheeks
+ Mouth puckering
+ Chewing problems

Other Possible Side Effects

While many people may not experience side effects or only have mild ones, it's essential to be aware of the following potential side effects:

Dizziness
Drowsiness
Fatigue
Weakness
Restlessness
Shakiness
Headache
Constipation
Dry mouth
Upset stomach
Weight gain
Increased appetite
Back pain
Joint pain
* Sleep disturbances

If you experience any of these side effects or have concerns about other symptoms, contact your doctor for guidance. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Uncontrolled muscle movements (face, tongue, limbs)
  • High fever, stiff muscles, confusion, sweating, fast or irregular heartbeat (signs of Neuroleptic Malignant Syndrome)
  • Increased thirst, frequent urination, increased hunger (signs of high blood sugar)
  • Dizziness or fainting when standing up
  • Severe drowsiness or sedation
  • Allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
  • Sore throat, fever, chills, or other signs of infection
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
All medications you are currently taking, including prescription and over-the-counter (OTC) medications, natural products, and vitamins. This information will help your doctor identify potential interactions between this medication and other substances.
* Any existing health problems you have. This information is crucial in determining the safety of taking this medication in conjunction with your other health conditions.

To ensure your safety, do not start, stop, or change the dosage of any medication without first consulting your doctor. It is vital to verify that it is safe to take this medication with all your other medications and health conditions. Your doctor and pharmacist will work together to assess potential interactions and ensure the safe use of this medication.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

When starting this medication, be cautious and avoid driving or engaging in activities that require alertness until you understand how it affects you. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying position, and be careful when climbing stairs.

Be aware that medications like this one can increase the risk of developing high blood sugar or diabetes, high cholesterol, and weight gain, which may contribute to heart and brain blood vessel disease. As directed by your doctor, monitor your blood sugar levels and undergo regular blood work and other laboratory tests.

It is recommended to avoid consuming alcohol while taking this medication. Before using marijuana, cannabis, or prescription or over-the-counter medications that may cause drowsiness, consult with your doctor.

This medication may cause dizziness, drowsiness, and impaired balance, which can increase the risk of falls and subsequent injuries, such as fractures.

In rare cases, a severe and potentially life-threatening reaction can occur, characterized by symptoms like fever, rash, swollen glands, and problems affecting organs such as the liver, kidney, blood, heart, muscles and joints, or lungs. If you have concerns, discuss them with your doctor.

Elderly patients with dementia who take medications like this one have a higher risk of experiencing strokes, which can be fatal. This medication is not approved for treating dementia-related mental health issues. If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

When administering this medication to children, exercise caution, as they may have a higher risk of experiencing certain side effects.

This medication may affect fertility, but this effect is reversible once the medication is discontinued. If you have questions, consult with your doctor.

If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor, as you will need to discuss the potential benefits and risks to both you and your baby. Taking this medication during the third trimester of pregnancy may cause side effects or withdrawal symptoms in the newborn.
🆘

Overdose Information

Overdose Symptoms:

  • Drowsiness
  • Slurred speech
  • Agitation
  • Tachycardia (fast heart rate)
  • Extrapyramidal symptoms (e.g., tremor, rigidity)
  • Coma
  • Respiratory depression
  • Hypotension
  • Seizures

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is supportive, including maintaining an open airway, oxygenation, and managing symptoms.

Drug Interactions

🔴

Major Interactions

  • CNS depressants (e.g., alcohol, benzodiazepines, opioids): Increased sedation, respiratory depression.
  • Anticholinergic drugs (e.g., benztropine, tricyclic antidepressants): Increased risk of anticholinergic side effects (e.g., constipation, urinary retention, dry mouth, blurred vision).
  • Drugs that prolong QT interval (e.g., Class IA and III antiarrhythmics, moxifloxacin, thioridazine): Increased risk of arrhythmias.
  • CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin): Increased olanzapine levels.
  • CYP1A2 inducers (e.g., carbamazepine, rifampin, omeprazole, smoking): Decreased olanzapine levels.
🟡

Moderate Interactions

  • Antihypertensive agents: Increased risk of orthostatic hypotension.
  • Levodopa and dopamine agonists: Olanzapine may antagonize their effects.
  • Valproate: Increased risk of neutropenia when co-administered with olanzapine.
  • Lithium: Increased risk of adverse events (e.g., tremor, sedation) when co-administered with olanzapine.
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Weight, BMI

Rationale: Risk of significant weight gain.

Timing: Prior to initiation

Fasting plasma glucose (FPG) or HbA1c

Rationale: Risk of hyperglycemia and new-onset diabetes mellitus.

Timing: Prior to initiation

Lipid panel (fasting triglycerides, LDL-C, HDL-C, total cholesterol)

Rationale: Risk of dyslipidemia.

Timing: Prior to initiation

Blood pressure

Rationale: Risk of orthostatic hypotension.

Timing: Prior to initiation

Personal and family history of cardiovascular disease, diabetes, dyslipidemia

Rationale: Assess baseline metabolic risk.

Timing: Prior to initiation

Complete Blood Count (CBC)

Rationale: Rare risk of leukopenia/neutropenia.

Timing: Prior to initiation (if clinically indicated)

Liver function tests (LFTs)

Rationale: Rare risk of hepatic enzyme elevations.

Timing: Prior to initiation (if clinically indicated)

ECG

Rationale: Assess for QT prolongation risk, especially in patients with cardiac disease or on other QT-prolonging drugs.

Timing: Prior to initiation (if clinically indicated)

📊

Routine Monitoring

Weight, BMI

Frequency: Monthly for first few months, then quarterly

Target: Maintain healthy BMI

Action Threshold: Significant weight gain (e.g., >5% baseline) warrants intervention.

Fasting plasma glucose (FPG) or HbA1c

Frequency: At 3 months, then annually (or more frequently if risk factors present)

Target: FPG <100 mg/dL, HbA1c <5.7%

Action Threshold: FPG â‰Ĩ126 mg/dL or HbA1c â‰Ĩ6.5% warrants diabetes management.

Lipid panel (fasting)

Frequency: At 3 months, then annually (or more frequently if risk factors present)

Target: LDL-C <100 mg/dL, Triglycerides <150 mg/dL

Action Threshold: Abnormal lipid levels warrant intervention.

Blood pressure

Frequency: At each visit

Target: Normal BP

Action Threshold: Orthostatic hypotension or sustained hypertension warrants intervention.

Abnormal Involuntary Movement Scale (AIMS)

Frequency: Annually (or more frequently if symptoms develop)

Target: No abnormal movements

Action Threshold: Emergence of tardive dyskinesia warrants reassessment of treatment.

Mental status, symptom control, side effects

Frequency: At each visit

Target: Improved symptoms, tolerable side effects

Action Threshold: Worsening symptoms or intolerable side effects warrant dose adjustment or change in therapy.

đŸ‘ī¸

Symptom Monitoring

  • Excessive sedation
  • Dizziness or lightheadedness (orthostatic hypotension)
  • Dry mouth, blurred vision, constipation, urinary retention (anticholinergic effects)
  • Muscle stiffness, tremor, restlessness (EPS)
  • Uncontrolled movements (tardive dyskinesia)
  • Increased thirst, urination, hunger (hyperglycemia)
  • Fever, muscle rigidity, altered mental status, autonomic instability (Neuroleptic Malignant Syndrome)
  • Sore throat, fever, signs of infection (agranulocytosis/neutropenia)

Special Patient Groups

🤰

Pregnancy

Category C. Use only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to antipsychotic drugs during the third trimester are at risk for extrapyramidal and/or withdrawal symptoms following delivery.

Trimester-Specific Risks:

First Trimester: Limited data, but no clear evidence of increased major congenital malformations.
Second Trimester: Limited data.
Third Trimester: Risk of extrapyramidal and/or withdrawal symptoms in neonates (e.g., agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress, feeding disorder).
🤱

Lactation

Olanzapine is excreted into breast milk. The American Academy of Pediatrics considers it a drug for which the effect on the nursing infant is unknown but may be of concern. Monitor infants for sedation, poor feeding, and weight gain.

Infant Risk: L3 (Moderately Safe - limited data, potential for adverse effects, but generally considered compatible with monitoring).
đŸ‘ļ

Pediatric Use

Not approved for use in children under 13 years of age. For adolescents (13-17 years) with schizophrenia or bipolar I mania, lower starting doses and careful titration are recommended due to higher rates of weight gain, dyslipidemia, and sedation compared to adults.

👴

Geriatric Use

Elderly patients, particularly those with dementia-related psychosis, are at increased risk of death when treated with antipsychotics. Olanzapine is not approved for this indication. Elderly patients may be more sensitive to the anticholinergic, hypotensive, and sedative effects. Consider lower starting doses and slower titration.

Clinical Information

💎

Clinical Pearls

  • Olanzapine ODT is bioequivalent to the conventional tablet and can be taken without water, which may be beneficial for patients with dysphagia or those who may be non-adherent to traditional tablets.
  • Significant weight gain and metabolic abnormalities (hyperglycemia, dyslipidemia) are common and require proactive monitoring and management.
  • Orthostatic hypotension is a risk, especially at initiation and with dose increases; advise patients to rise slowly.
  • Sedation is a common side effect, often leading to once-daily dosing at bedtime.
  • While generally having a lower risk of EPS than first-generation antipsychotics, EPS and tardive dyskinesia can still occur.
  • Smoking (due to CYP1A2 induction) can significantly reduce olanzapine levels, potentially requiring higher doses in smokers.
🔄

Alternative Therapies

  • Other atypical antipsychotics (e.g., Aripiprazole, Quetiapine, Risperidone, Lurasidone, Cariprazine, Brexpiprazole, Ziprasidone)
  • Mood stabilizers (e.g., Lithium, Valproate, Carbamazepine, Lamotrigine) for bipolar disorder.
  • First-generation antipsychotics (e.g., Haloperidol, Chlorpromazine) for schizophrenia.
💰

Cost & Coverage

Average Cost: Varies widely (e.g., $30-$300+) per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 (generic); Tier 3 or 4 (brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further evaluation and guidance. To ensure your safety and the effectiveness of your treatment, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, which is a patient fact sheet that provides crucial information about its use. It is important to read this guide carefully and review it again whenever your prescription is refilled. If you have any questions or concerns about this medication, do not hesitate to consult with your doctor, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide detailed information, including the name of the medication taken, the amount, and the time it was taken.